Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011
Although Moraxella catarrhalis is known to be susceptible to macrolides, highly macrolide-resistant M. catarrhalis isolates have recently been reported in Japan and China. In this study, we investigated the prevalence of macrolide-resistant M. catarrhalis isolates in Tokyo and Chiba, Japan, and studied the mechanisms underlying their resistance. Specifically, we determined the susceptibility of 593 clinical isolates (collected between December 2011 and May 2014) to erythromycin, using the disk diffusion method. For isolates with erythromycin resistance, we identified the MICs of seven antimicrobial agents, including macrolides, and used PFGE to analyse the clonal spread. We also performed sequencing analysis to investigate macrolide-resistance targets. Thirteen isolates (2.2 %) were found to be resistant to erythromycin, showing a high MIC90 to erythromycin, clarithromycin, clindamycin and azithromycin. However, those isolates, in addition to 156 randomly selected erythromycin-susceptible strains, were susceptible to amoxicillin–clavulanate, cefixime and levofloxacin. The 13 highly macrolide-resistant isolates were classified into 10 clades and harboured three or four A2058T-mutated 23S rRNA alleles. Three highly macrolide-resistant isolates also exhibited mutations in ribosomal proteins L4 (V27A and R161C) and L22 (K68T). To the best of our knowledge, we have demonstrated for the first time that, whilst the prevalence of macrolide-resistant M. catarrhalis isolates is low in clinical settings in Japan, genetically diverse isolates with high-level macrolide resistance due to the acquisition of an A2058T mutation in the 23S rRNA have already spread. Our study therefore lays the basis for epidemiological studies of macrolide-resistant M. catarrhalis clinical isolates.
ChungW.O., WerckenthinC., SchwarzS., RobertsM.C.1999; Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J Antimicrob Chemother 43:5–14 [View Article][PubMed]
CLSI2010Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Approved Standard M45-A2 Wayne, PA: Clinical and Laboratory Standards Institute;
FarrellD.J., FlammR.K., JonesR.N., SaderH.S.2013; Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010). Diagn Microbiol Infect Dis 75:86–88 [View Article][PubMed]
IwataS., SatoY., ToyonagaY., HanakiH., SunakawaK.2015; Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones. J Infect Chemother 21:308–311 [View Article][PubMed]
LehtopolkuM., KotilainenP., Haanperä-HeikkinenM., NakariU.M., HänninenM.L., HuovinenP., SiitonenA., EerolaE., JalavaJ., HakanenA.J.2011; Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuniCampylobacter coli
. Antimicrob Agents Chemother 55:5939–5941 [View Article][PubMed]
LiuY., ZhaoC., ZhangF., ChenH., ChenM., WangH.2012; High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China. Microb Drug Resist 18:417–426 [View Article][PubMed]
PauknerS., SaderH.S., Ivezic-SchoenfeldZ., JonesR.N.2013; Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010. Antimicrob Agents Chemother. 57:4489–4495 [View Article][PubMed]
RobertsM.C.2008; Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 282:147–159 [View Article][PubMed]
SaitoR., NonakaS., FujinamiY., MatsuokaS., NakajimaS., NishiyamaH., OkamuraN.2014; The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis
. J Infect Chemother 20:6–8 [View Article][PubMed]
SethiS., MurphyT.F.2008; Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359:2355–2365 [View Article][PubMed]
WatanabeA., YanagiharaK., MatsumotoT., KohnoS., AokiN., OguriT., SatoJ., MurataniT., YagisawaM., other authors. 2012; Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility. J Infect Chemother 18:609–620 [View Article][PubMed]
Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011